1naresh2naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) [c507118f-b62f-4b86-a6c7-84ff844848b0] => Array ( [runtime-id] => c507118f-b62f-4b86-a6c7-84ff844848b0 [type] => toll-free-key [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [2059aba9-5624-45a3-9fcf-670e78011da8] => Array ( [runtime-id] => 2059aba9-5624-45a3-9fcf-670e78011da8 [type] => toll-free-key ) ) [credentials] => Array ( [method] => toll-free-key [value] => tf_ipsecsha;f9ce5cbf3b6cd627ff5a2ca39c6d0574e48f4bcf ) ) ) 1naresh2nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) [c507118f-b62f-4b86-a6c7-84ff844848b0] => Array ( [runtime-id] => c507118f-b62f-4b86-a6c7-84ff844848b0 [type] => toll-free-key [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [2059aba9-5624-45a3-9fcf-670e78011da8] => Array ( [runtime-id] => 2059aba9-5624-45a3-9fcf-670e78011da8 [type] => toll-free-key ) ) [credentials] => Array ( [method] => toll-free-key [value] => tf_ipsecsha;f9ce5cbf3b6cd627ff5a2ca39c6d0574e48f4bcf ) ) )TABLE 8:Imaging protocols for acceptable PCT results
Bolus (mL) No. of Boluses Total (mL) Scanning Duration (seconds) Temporal Sampling Interval (seconds) Images per Series (per section) PCT Technique MDCT Spatial Coverage (cm) kVp mAs mSv Dose-Coverage Ratio Image-Quality Ratio 30 2 60 36 2 19 Cine 4 80 120 1.245 0.311 0.645 30 3 90 36 2 19 Cine 6 80 120 1.867 0.311 0.645 40 2 80 42 3 15 Cine 4 80 120 0.983 0.246 0.712 50 2 100 42 3 15 Cine 4 80 120 0.983 0.246 0.767 60 1 60 48 4 13 Toggling-table 4 80 120 0.852 0.213 0.850
Note.—Parameters in boldface indicate the recommended protocols with optimal dose-coverage ratios.